Listen "Is the Fountain of Youth Finally Open for Business?"
Episode Synopsis
From CRISPR breakthroughs to AI-powered drug discovery, longevity science is moving from myth to marketplace. Host Andrew Wilkinson sits down with Alex Gunz, Portfolio Manager at Heptagon Capital, to explore how innovations in genomics, stem cells, and personalized medicine could redefine healthcare — and reshape the investment landscape. Discover why the race to extend lifespan may also unlock new long-term returns.
More episodes of the podcast IBKR Podcasts
Can You Really Trade on the Future?
08/10/2025
Make Subsidies Great Again?
06/10/2025
Is AI About to Blow a Fuse?
25/09/2025
Is Volatility Playing Hide-and-Seek?
24/09/2025
A 1970s Warning for 2025
19/09/2025
The Dot Plot Thickens
17/09/2025
The Chart Whisperer: Markets in Motion
16/09/2025